Documents (407) JSON TSV

source DB	source ID	text	size	updated at	# proj.	# Ann.	updated_at
PubMed	7438115	Relationship of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer. The qualitative and quantitative relationships between cytoplasmic estrogen receptors (ERC	1.11 KB	2015-03-12	2	8	-
PubMed	3298786	Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas. Molecular studies have demonstrated increased expression of the Harvey (Ha) ras oncogene in human breast and co	1.58 KB	2015-11-27	4	10	-
PubMed	2440556	Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas. To assess the postulated correlation between plasminogen activators (PAs) and malignancy, we deter	1.07 KB	2015-11-26	5	10	-
PubMed	2910450	Transport and metabolism of 1-beta-D-arabinofuranosylcytosine in human ovarian adenocarcinoma cells. 1-beta-D-Arabinofuranosylcytosine (araC) is an effective drug in the i.p. therapy of ovarian carcin	1.39 KB	2015-03-12	3	8	-
PubMed	2521857	Phorbol ester or epidermal growth factor (EGF) stimulates the concurrent accumulation of mRNA for the EGF receptor and its ligand transforming growth factor-alpha in a breast cancer cell line. We have	1.59 KB	2015-11-27	25	8	-
PubMed	2516715	Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters. In the present study	2.41 KB	2015-03-12	3	11	-
PubMed	1978301	Flutamide has no effect on adrenal androgen response to acute ACTH stimulation in patients with prostatic cancer. Basal levels and adrenocorticotropic hormone (ACTH)-induced increments (delta-values)	1.41 KB	2015-12-07	3	8	-
PubMed	1985102	The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta. Recent experimental work has identified a novel intracellul	1.34 KB	2015-12-07	3	8	-
PubMed	1541865	[The clinical significance of thrombin-antithrombin III complex (TAT) and fibrinogen and fibrin degradation products (FDP) levels in ovarian cancer]. We measured the levels of thrombin-antithrombin II	1.37 KB	2015-11-22	3	8	-
PubMed	1349318	Histochemical staining of protein-tyrosine phosphatase activity in primary human mammary carcinoma: relationship with established prognostic indicators. Protein-tyrosine phosphatase (PTPase) activity	1.46 KB	2015-11-22	3	10	-